Fidelity Investments’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.15B | Buy |
13,160,167
+3,232,231
| +33% | +$497M | 0.11% | 153 |
|
|
2025
Q4 | $1.73B | Buy |
9,927,936
+746,973
| +8% | +$136M | 0.09% | 179 |
|
|
2025
Q3 | $1.32B | Buy |
9,180,963
+4,087,702
| +80% | +$501M | 0.07% | 224 |
|
|
2025
Q2 | $513M | Buy |
5,093,261
+1,698,877
| +50% | +$130M | 0.03% | 479 |
|
|
2025
Q1 | $259M | Sell |
3,394,384
-1,461,865
| -30% | -$112M | 0.02% | 697 |
|
|
2024
Q4 | $335M | Sell |
4,856,249
-2,335,269
| -32% | -$168M | 0.02% | 616 |
|
|
2024
Q3 | $525M | Sell |
7,191,518
-113,612
| -2% | -$8.38M | 0.03% | 463 |
|
|
2024
Q2 | $489M | Sell |
7,305,130
-2,013,764
| -22% | -$78.1M | 0.03% | 454 |
|
|
2024
Q1 | $253M | Buy |
9,318,894
+4,227,280
| +83% | +$118M | 0.02% | 707 |
|
|
2023
Q4 | $158M | Buy |
5,091,614
+786,660
| +18% | +$20.4M | 0.01% | 842 |
|
|
2023
Q3 | $109M | Buy |
4,304,954
+221,659
| +5% | +$5.07M | 0.01% | 932 |
|
|
2023
Q2 | $86.2M | Buy |
4,083,295
+496,295
| +14% | +$9.42M | 0.01% | 1062 |
|
|
2023
Q1 | $61.2M | Sell |
3,587,000
-181,407
| -5% | -$3.52M | 0.01% | 1177 |
|
|
2022
Q4 | $75.3M | Buy |
3,768,407
+221,101
| +6% | +$4.27M | 0.01% | 1082 |
|
|
2022
Q3 | $76.4M | Buy |
3,547,306
+118,820
| +3% | +$2.85M | 0.01% | 1063 |
|
|
2022
Q2 | $67.6M | Buy |
3,428,486
+63,548
| +2% | +$1.33M | 0.01% | 1126 |
|
|
2022
Q1 | $79.1M | Sell |
3,364,938
-180,293
| -5% | -$4.19M | 0.01% | 1185 |
|
|
2021
Q4 | $96.6M | Sell |
3,545,231
-456,863
| -11% | -$13.1M | 0.01% | 1115 |
|
|
2021
Q3 | $110M | Sell |
4,002,094
-333,312
| -8% | -$8.74M | 0.01% | 1063 |
|
|
2021
Q2 | $123M | Sell |
4,335,406
-1,634,550
| -27% | -$48.5M | 0.01% | 1028 |
|
|
2021
Q1 | $203M | Sell |
5,969,956
-6,118,588
| -51% | -$234M | 0.02% | 782 |
|
|
2020
Q4 | $402M | Sell |
12,088,544
-3,133,562
| -21% | -$114M | 0.04% | 470 |
|
|
2020
Q3 | $489M | Buy |
15,222,106
+288,225
| +2% | +$8.28M | 0.05% | 342 |
|
|
2020
Q2 | $411M | Buy |
14,933,881
+1,467,747
| +11% | +$34.8M | 0.05% | 368 |
|
|
2020
Q1 | $216M | Buy |
13,466,134
+64,606
| +0.5% | +$1.53M | 0.03% | 485 |
|
|
2019
Q4 | $320M | Buy |
13,401,528
+659,239
| +5% | +$13.4M | 0.04% | 461 |
|
|
2019
Q3 | $225M | Buy |
12,742,289
+2,153,573
| +20% | +$41.6M | 0.03% | 589 |
|
|
2019
Q2 | $271M | Sell |
10,588,716
-1,042,068
| -9% | -$29M | 0.03% | 541 |
|
|
2019
Q1 | $338M | Buy |
11,630,784
+67,250
| +0.6% | +$1.74M | 0.04% | 438 |
|
|
2018
Q4 | $152M | Buy |
11,563,534
+7,406
| +0.1% | +$118K | 0.02% | 688 |
|
|
2018
Q3 | $234M | Buy |
11,556,128
+62,658
| +0.5% | +$1.41M | 0.03% | 617 |
|
|
2018
Q2 | $272M | Buy |
11,493,470
+779
| +0% | +$20.1K | 0.03% | 545 |
|
|
2018
Q1 | $259M | Buy |
11,492,691
+4,040
| +0% | +$106K | 0.03% | 581 |
|
|
2017
Q4 | $358M | Buy |
11,488,651
+13,717
| +0.1% | +$405K | 0.04% | 461 |
|
|
2017
Q3 | $358M | Buy |
11,474,934
+2,171,118
| +23% | +$41.4M | 0.04% | 454 |
|
|
2017
Q2 | $160M | Buy |
9,303,816
+299
| +0% | +$5.11K | 0.02% | 764 |
|
|
2017
Q1 | $163M | Buy |
9,303,517
+21,832
| +0.2% | +$337K | 0.02% | 782 |
|
|
2016
Q4 | $123M | Hold |
9,281,685
| – | – | 0.02% | 884 |
|
|
2016
Q3 | $135M | Buy |
9,281,685
+848,911
| +10% | +$10.6M | 0.02% | 841 |
|
|
2016
Q2 | $83.1M | Sell |
8,432,774
-845,858
| -9% | -$9.87M | 0.01% | 1067 |
|
|
2016
Q1 | $118M | Buy |
9,278,632
+8,070
| +0.1% | +$106K | 0.02% | 896 |
|
|
2015
Q4 | $168M | Buy |
9,270,562
+6,523
| +0.1% | +$115K | 0.02% | 723 |
|
|
2015
Q3 | $172M | Buy |
9,264,039
+38,774
| +0.4% | +$968K | 0.02% | 705 |
|
|
2015
Q2 | $225M | Buy |
9,225,265
+607,751
| +7% | +$13.8M | 0.03% | 637 |
|
|
2015
Q1 | $179M | Buy |
8,617,514
+1,167,765
| +16% | +$20.6M | 0.02% | 740 |
|
|
2014
Q4 | $115M | Buy |
7,449,749
+223,291
| +3% | +$3.17M | 0.02% | 940 |
|
|
2014
Q3 | $94.3M | Buy |
7,226,458
+1,335,583
| +23% | +$20.1M | 0.01% | 994 |
|
|
2014
Q2 | $118M | Buy |
5,890,875
+1,439
| +0% | +$21.3K | 0.02% | 917 |
|
|
2014
Q1 | $112M | Buy |
5,889,436
+23,000
| +0.4% | +$437K | 0.02% | 924 |
|
|
2013
Q4 | $99.8M | Buy |
5,866,436
+715,249
| +14% | +$11M | 0.01% | 986 |
|
|
2013
Q3 | $80.4M | Buy |
5,151,187
+1,393,647
| +37% | +$17.7M | 0.01% | 1055 |
|
|
2013
Q2 | $44.9M | Buy |
+3,757,540
| New | +$38.4M | 0.01% | 1291 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Fidelity Investments's INSM Position: Q1 2026 in Review
Fidelity Investments increased its Insmed (INSM) stake by 33% in Q1 2026, buying an estimated $497M and bringing the position to 13,160,167 shares worth $2.15B. The position accounts for 0.11% of the portfolio, ranked #153.
Fidelity Investments first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Fidelity Investments held 13,160,167 shares of Insmed worth $2.15B as of Q1 2026.
- Fidelity Investments bought 3,232,231 Insmed shares in Q1 2026, an estimated $497M.
- Insmed made up 0.11% of Fidelity Investments's portfolio in Q1 2026, its #153 holding.
- Fidelity Investments first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
- 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.